Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rondo Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rondo Therapeutics

Rondo Therapeutics

Series A

Rondo Therapeutics: Developing novel bispecific antibodies to combat cancer, since 2021.

HQ
Hayward, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Rondo Therapeutics, founded in 2021 and headquartered in Hayward, California, focuses on developing novel bispecific antibodies to combat cancer. The company's core mission is to harness the immune system to safely target and eliminate tumors, specifically solid tumors, while maximizing efficacy and minimizing side effects. Rondo Therapeutics aims to revolutionize cancer treatment through its innovative approach to immune-cell engaging bispecific antibodies.

The company is supported by top investors and guided by a dynamic team of seasoned entrepreneurs, exceptional scientists, and industry-leading advisors. Rondo Therapeutics has made significant strides in its pipeline development, positioning itself as a promising player in the oncology sector. Its impact lies in its potential to offer more effective and safer cancer therapies, contributing to the advancement of immuno-oncology.

Rondo Therapeutics - Similar Companies

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Crossbow Therapeutics logo

Crossbow Therapeutics

crossbowtx.com

Trio Pharmaceuticals logo

Trio Pharmaceuticals

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Valink Therapeutics logo

Valink Therapeutics

valinktx.com

Solve Therapeutics logo

Solve Therapeutics

OncoResponse logo

OncoResponse

Marengo Therapeutics logo

Marengo Therapeutics

marengotx.com

Dren Bio logo

Dren Bio

drenbio.com

RevOpsis Therapeutics logo

RevOpsis Therapeutics

revopsis.com

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

SunnyBay BioTech logo

SunnyBay BioTech

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

LiliumX logo

LiliumX

liliumx.com

Rondo Therapeutics - Quick Facts

Who are Rondo Therapeutics' competitors?

Companies similar to Rondo Therapeutics include Immune-Onc Therapeutics, Soteria Biotherapeutics, Crossbow Therapeutics and Trio Pharmaceuticals.

When was Rondo Therapeutics founded?

Rondo Therapeutics was founded in 2019.

Where is Rondo Therapeutics' headquarters located?

Rondo Therapeutics' headquarters is located in Hayward, CA, US.

When was Rondo Therapeutics' last funding round?

Rondo Therapeutics' most recent funding round was for $67M (USD) in March 2022.

How much has Rondo Therapeutics raised to-date?

As of Mar 2, 2022, Rondo Therapeutics has raised a total of $67M (USD).

How many employees does Rondo Therapeutics have?

Rondo Therapeutics has 12 employees as of Feb 4, 2024.

Rondo Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibodies
  • Cancer Treatment
Tags
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified